Scientific exchange · Dr. Zoë Bauer

31 May 2026 · Phone · Dr. Zoë Bauer, McGill University Health Centre · MSL Luis Ortega · Lumeva

ReviewedVeeva CRMENG-0168—

Capture insight from this engagement

Location: McGill University Health Centre
Therapeutic area: Neurology
Country: Canada
Stakeholder tier: Tier 2
Strategic objective: Not linked
Initiative: Not linked
MSL: LOLuis OrtegaMSL, Neurology (Iberia)
Product: Lumeva (lumevarin)

Topics discussed

Dosing in hepatic impairment
Drug interactions
Switching between CGRP agents

Scientific content used

LMV persistence data summary
Chronic migraine scientific platform

Questions raised

No questions recorded.

Notes

Scientific exchange with primary care physician at McGill University Health Centre. Discussed dosing in hepatic impairment, drug interactions, switching between cgrp agents.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Schedule follow-up in 6 weeks

0 of 1 complete

Quality ratings

1–5, rated at review

Scientific relevance: 3
Strategic relevance: 5
Depth of exchange: 3
Actionability: 1

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0168

Audit history (0)

All create, update and approval events for this record

No audit events in sample data